Bringing genomics closer to patients: 3 takeaways from Henry Ford Health
Becker's Healthcare December 19, 2024
In an interactive session at Becker’s 12th Annual CEO + CFO Roundtable, two leaders from Illumina — Mike Kreitzinger, lead of health system strategy, and Damon Hostin, lead of market access for health systems — facilitated a discussion with Tom Mikkelsen, MD, medical director of the precision medicine program and clinical trials at Detroit-based Henry Ford Health.
The session highlighted Henry Ford Health’s progress in precision medicine, which began with a focus on oncology and has since expanded to other areas like cardiology. The panelists also discussed the importance of genomics in personalized medicine, highlighting advancements in molecular diagnostics and their integration into routine care. Opportunities for increasing patients’ access to innovative diagnostics and clinicians’ awareness and buy-in of new...